Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives

Psychiatric Genetics

Volumn 20, Issue 1, 2010, Pages 14-19

  Kucukali, Cem Ismail ^a   Aydin, Makbule ^b   Ozkok, Elif ^b   Bilge, Emine ^b   Zengin, Asli ^b   Cakir, Ulku ^c   Kara, Ihsan ^b  

^a Istanbul Erenkoy Psychiatric and Neurological Disorders Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c VAKIF GUREBA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Angiotensin converting enzyme; Bipolar disorders; Gene variant; Relatives; Schizophrenia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ALLELES; BIPOLAR DISORDER; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 75149194357     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283351194     Document Type: Article

References (57)

1. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, Mendelsohn FA (1998). Angiotensin receptors in the nervous system. Brain Res Bull 47:17-28.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorder. 4th ed. Washington DC: American Psychiatric Association, American Psychiatric Press.
3. Andreasan NC (1990). Methods for assessing positive and negative symptoms. Mod Probl Pharmacopsychiatry 24:73-88.
4. Arinami T, Li L, Mitsushio H, Itokawa M, Hamaguchi H, Toru M (1996). An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatry 40:1122-1127. (Pubitemid 26400876)
5. Arregui A, MacKay AV, Iversen LL, Spokes EG (1979). Reduction of angiotensinconverting enzyme in subtantia nigra in early-onset schizophrenia. N Engl J Med 300:502-503.
6. Arregui A, MacKay AV, Spokes EG, Iversen LL (1980). Reduced activity of angiotensin converting enzyme in basal ganglia in early onset schizophrenia. Psychol Med 10:307-313.
7. Banks RJ, Mozley L, Dourish CT (1994). The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat. Neuroscience 58:799-805.
8. Bardenstein KK, McGlashan TH (1990). Gender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr Res 3:159-172.
9. Barnes C, Mitchell P (2005). Considerations in the management of bipolar disorder in women. Aust N Z J Psychiatry 38:662-673.
10. Beckmann H, Saavedra JM, Gattaz WF (1984). Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. Biol Psychiatry 19:679-684.
11. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI Jr, Gershon ES (1994). Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci U S A 21:5918-5921.
12. Berrettini WH, Ferraro TN, Goldin LR, Detera-Wadleigh SD, Choi H, Muniec D, et al. (1997). A linkage study of bipolar illness. Arch Gen Psychiatry 54:27-35.
13. Bramon E, Sham PC (2001). The common genetic liability between schizophrenia and bipolar disorder: a review. Curr Psychiatry Rep 3:332-337.
14. Burt VK, Stein K (2002). Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 63:9-15.
15. Burt VK, Rasgon N (2004). Specific considerations in treating bipolar disorder in women. Bipolar Disord 6:2-13.
16. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. (1992). Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644.
17. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002). A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159:539-545.
18. Carlsson A,Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001). Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260.
19. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980). The extrapyramidal symptom rating scale. Can J Neurol Sci 7:233.
20. Endicott J, Spitzer RL (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-862.
21. First MB, Spitzer RL, Williams JBW (1997). Structured Clinical Interview for DSM-IV SCID-I). Washington DC: American Psychiatric Association.
22. Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI Jr, Maxwell ME, Schreiber J, et al. (1988). A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 45:328-336.
23. Hall MH, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, et al. (2008). Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression. A combined twin and family study. Am J Med Genet B Neuropsychiatr Genet 147B:619-627.
24. Jenkins TA, Chai SY, Mendelsohn FAO (1997a). Effect of angiotensin II on striatal dopamine release in the spontaneous hypertensive rat. Clin Exp Hypertens 19:645-658.
25. Jenkins TA, Chai SY, Mendelsohn FAO (1997b). Upregulation of angiotensin II AT1 receptors in the mouse nucleus accumbens by chronic haloperidol treatment. Brain Res 748:137-142.
26. Jenkins TA, Mendelsohn FAO, Chai SY (1997c). Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem 68:1304-1311.
27. Kara I, Ozkok E, Aydin M, Orhan N, Cetinkaya Y, Gencer M, et al. (2007). Combined effects of ACE and MMP-3 polymorphisms on migraine development. Cephalalgia 27:235-243.
28. Konuk N, Atik L, Simsekyilmaz O, Dursun A, Acikgoz S (2006). Association of angiotensin converting enzyme gene polymorphism and affective disorders in Turkish patients. Aust N Z J Psychiatry 40:717-718.
29. Laursen TM, Labouriau R, Licht RW, Bertelsen A, Munk-Olsen T, Mortsensen PB (2005). Family history of psychiatric illness as a risk factor for schizoaffective disorder. Arch Gen Psychiatry 62:841-848.
30. Leibenluft E (1996). Women with bipolar illness: clinical and research issues. Am J Psychiatry 153:163-173.
31. Leibenluft E (1999). Gender differences in major depressive disorder and bipolar disorder. CNS Spect 4:25-33.
32. Lewine RR, Walker EF, Shurett R, Caudle J, Haden C (1996). Sex differences in neuropsychological functioning among schizophrenic patients. Am J Psychiatry 153:1178-1184.
33. Magaro PA, Abrams L, Cantrell P (1981). The maine scale of paranoid and nonparanoid schizophrenia: reliability and validity. J Consult Clin Psychol 49:438-447.
34. Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O, Levinson DF (1993). Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch Gen Psychiatry 50:871-883.
35. Meira-Lima IV, Pereira AC, Mota GF, Krieger JE, Vallada H (2000). Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans. Neurosci Lett 293:103-106.
36. Mendelsohn FA, Allen AM, Chai SY, McKinley MJ, Oldfield BJ, Paxinos G (1990). The brain angiotensin system. Insights from mapping its components. Trends Endocrinol Metab 1:189-199.
37. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
38. Moore R, Krstew EV, Kirchoff J, Davisson RL, Lawrence AJ (2007). Central overexpression of angiotensin AT1A receptors prevents dopamine D2 receptor regulation of alcohol consumption in mice. Alcohol Clin Exp Res 31:1128-1137.
39. Oksanen V, Fyhrquist H, Somer H, Gronhagen-Riska C (1985). Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology 35:1220-1223.
40. Ouyang WC,Wang YC, Hong CJ, Cheng CY, Tsai SJ (2001). Association study of angiotensin-converting enzyme gene polymorphism with schizophrenia and polydipsia. Neuropsychobiology 44:31-35.
41. Overal JE, Gorhan DR (1962). The brief psychiatric rating scale. Psychol Rep 10:799-812.
42. Owen F, Lofthouse R, Crow TJ (1980). Angiotensin-converting enzyme in substantia nigra of schizophrenics. New Eng J Med 303:528-529.
43. Pauls J, Bandelow B, Ruther E, Kornhuber J (2000). Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder. J Neural Transm 107:1361-1366.
44. Pearlson GD, Kim WS, Kubos KL, Moberg PJ, Jayaram G, Bascom MJ, et al. (1989). Ventricule-brain ratio, computed tomographic density, and brain area in 50 schizophrenics. Arch Gen Psychiatry 46:690-697.
45. Pearlson GD, Barta PE, Powers RE, Menon RR, Richard SS, Aylward EH, et al. (1997). Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 41:1-14.
46. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al. (1993). Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075.
47. Rigat B, Hubert C, Alhens-Gelas F, Cambien F, Corvol P, Soubrier F (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346.
48. Rigat B, Hubert P, Corvol P, Soubrier F (1992). PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxy peptidase). Nucl Acid Res 20:1433.
49. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. (1994). Association between a deletion polymorphism of the angiotensinconverting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638.
50. Sharma P, Carter ND, Barley J, Brown MM (1994). Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertension 8:645-648.
51. Tsuang MT, Winokur G, Crowe RR (1980). Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry 137:497-504.
52. Tsutsumi K, Saavedra JM (1991). Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 261:R209.
53. Wahlbeck K, Rimon R, Fyhrquist F (1993). Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patients. Schizophr Res 9:77-82.
54. Winokur G, Tsuang MT, Crowe RR (1982). The Iowa 500: affective disorder in relatives of manic and depressed patients. Am J Psychiatry 139:209-212.
55. Winokur G, Scharfetter C, Angst J (1985). A family study of psychotic symptomatology in schizophrenia, schizoaffective disorder, unipolar depression, and bipolar disorder. Eur Arch Psychiatry Neurol Sci 234:295-298.
56. Wright JW, Harding JW (1992). Regulatory role of brain angiotensins in the central of physiological and behavioral responses. Brain Res Rev 17:227-262.
57. Wright JW, Harding JW (1994). Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 18:21-53.